Untitled, PharmaLive: RXi Pharmaceuticals and the University of Massachusetts Medical School Announce Massachusetts Life Sciences Center Cooperative Research Grant for RNAi Therapeutics for ALS

Center funding will support $1 million for innovative research projects with scientific and commercial potential WORCESTER, Mass.